Unibest

Pharmaceutical intermediates

Molnupiravir Intermediates

1 pharmaceutical intermediate for Molnupiravir. Indication: SARS-CoV-2 infection.

Submit a ProjectAll intermediates

About Molnupiravir

Originator
Emory University
Indication
SARS-CoV-2 infection

Available intermediates

1 intermediate currently listed for Molnupiravir. Request specifications, documentation or a quotation for any item below.

Molnupiravir intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate2346620-55-9//

Other programs under M

MaribavirMaxacalcitolMetoclopramide HClMicafungin SodiumMilvexianMirogabalin besilateMomelotinib Dihydrochloride MonohydrateMoxifloxacin hydrochloride

Building toward Molnupiravir?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →